QFITLIA
Live / Registered — Registered (as of 02 Sept 2025)
What this means for you
Registered since 02 Sept 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90836577
- Registration number
- 7930796
- Mark type
- Stylized text
- Filed
- 19 Jul 2021
- Published for opposition
- 19 Apr 2022
- Registered
- 02 Sept 2025
- Attorney of record
- Alexandra Kochian
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of hemophilia
Owner
- Genzyme Corporation, Cambridge, MA, US
- Genzyme Corporation, Cambridge, MA, US
- Genzyme Corporation, Cambridge, MA, US
Prosecution history
- 02 Sept 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 02 Sept 2025 — REGISTERED-PRINCIPAL REGISTER
- 14 Aug 2025 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 14 Aug 2025 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 14 Aug 2025 — STATEMENT OF USE PROCESSING COMPLETE
- 15 Apr 2025 — USE AMENDMENT FILED
- 26 Jun 2025 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 26 Jun 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 26 Jun 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 26 Jun 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 15 Apr 2025 — TEAS STATEMENT OF USE RECEIVED
- 23 Oct 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 23 Oct 2024 — SOU EXTENSION 5 GRANTED
- 23 Oct 2024 — SOU EXTENSION 5 FILED
- 23 Oct 2024 — SOU TEAS EXTENSION RECEIVED